Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joshua S. Self is active.

Publication


Featured researches published by Joshua S. Self.


Applied and Environmental Microbiology | 2010

Presence of Coxiella burnetii DNA in the environment of the United States, 2006 to 2008.

Gilbert J. Kersh; Teresa M. Wolfe; Kelly A. Fitzpatrick; Amanda J. Candee; Lindsay D. Oliver; Nicole E. Patterson; Joshua S. Self; Rachael A. Priestley; Amanda D. Loftis; Robert F. Massung

ABSTRACT Coxiella burnetii is an obligate intracellular bacterium that causes the zoonotic disease Q fever. Because C. burnetii is highly infectious, can survive under a variety of environmental conditions, and has been weaponized in the past, it is classified as a select agent and is considered a potential bioweapon. The agent is known to be present in domestic livestock and in wild animal populations, but the background levels of C. burnetii in the environment have not been reported. To better understand the amount of C. burnetii present in the environment of the United States, more than 1,600 environmental samples were collected from six geographically diverse parts of the United States in the years 2006 to 2008. DNA was purified from these samples, and the presence of C. burnetii DNA was evaluated by quantitative PCR of the IS1111 repetitive element. Overall, 23.8% of the samples were positive for C. burnetii DNA. The prevalence in the different states ranged from 6 to 44%. C. burnetii DNA was detected in locations with livestock and also in locations with primarily human activity (post offices, stores, schools, etc.). This study demonstrates that C. burnetii is fairly common in the environment in the United States, and any analysis of C. burnetii after a suspected intentional release should be interpreted in light of these background levels. It also suggests that human exposure to C. burnetii may be more common than what is suggested by the number of reported cases of Q fever.


Journal of General Virology | 2009

A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus.

Christina L. Hutson; Victoria A. Olson; Darin S. Carroll; Jason Abel; Christine M. Hughes; Zachary Braden; Sonja Weiss; Joshua S. Self; Jorge E. Osorio; Paul N. Hudson; Michael Dillon; Kevin L. Karem; Inger K. Damon; Russell L. Regnery

Multiple monkeypox virus (MPXV) animal models have been discussed in previous studies, but no small animal models, nor most non-human primate models, demonstrated the protracted asymptomatic incubation phase seen in systemic human orthopoxvirus illness. Herein, we characterize a black-tailed prairie dog (PD) (Cynomys ludovicianus) model of infection, via intranasal and intradermal exposures, with the two MPXV clades. Daily observations of the animals were made (food consumption, general symptoms, disease presentation), while weights and virus evaluations (ocular, nasal, oropharyngeal, faeces, blood) were obtained/made every third day. Generalized rash became apparent 9-12 days post-infection for all animals. Individual animals demonstrated a range of symptoms consistent with human monkeypox disease. Measurable viraemias and excretas were similar for both clade-representative strains and persisted until at least day 21. Greater morbidity was observed in Congo Basin strain-challenged animals and mortality was observed only in the Congo Basin strain-challenged animals. The PD model is valuable for the study of strain-dependent differences in MPXV. Additionally, the model closely mimics human systemic orthopoxvirus disease and may serve as a valuable non-human surrogate for investigations of antivirals and next generation orthopoxvirus vaccines.


Applied and Environmental Microbiology | 2013

Presence and Persistence of Coxiella burnetii in the Environments of Goat Farms Associated with a Q Fever Outbreak

Gilbert J. Kersh; Kelly A. Fitzpatrick; Joshua S. Self; Rachael A. Priestley; Aubree J. Kelly; R. Ryan Lash; Nicola Marsden-Haug; Randall J. Nett; Adam Bjork; Robert F. Massung; Alicia D. Anderson

ABSTRACT Q fever is a zoonotic disease caused by inhalation of the bacterium Coxiella burnetii. Ruminant livestock are common reservoirs for C. burnetii, and bacteria present in aerosols derived from the waste of infected animals can infect humans. The significance of infection from material deposited in the environment versus transmission directly from infected animals is not known. In 2011, an outbreak of Q fever cases on farms in Washington and Montana was associated with infected goats. A study was undertaken to investigate the quantity and spatial distribution of C. burnetii in the environment of these goat farms. Soil, vacuum, and sponge samples collected on seven farms epidemiologically linked to the outbreak were tested for the presence of C. burnetii DNA by quantitative PCR. Overall, 70.1% of the samples were positive for C. burnetii. All farms had positive samples, but the quantity of C. burnetii varied widely between samples and between farms. High quantities of C. burnetii DNA were in goat housing/birthing areas, and only small quantities were found in samples collected more than 50 m from these areas. Follow-up sampling at one of the farms 1 year after the outbreak found small quantities of C. burnetii DNA in air samples and large quantities of C. burnetii persisting in soil and vacuum samples. The results suggest that the highest concentrations of environmental C. burnetii are found in goat birthing areas and that contamination of other areas is mostly associated with human movement.


Virology | 2010

Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease.

Christina L. Hutson; Darin S. Carroll; Joshua S. Self; Sonja Weiss; Christine M. Hughes; Zachary Braden; Victoria A. Olson; Scott K. Smith; Kevin L. Karem; Russell L. Regnery; Inger K. Damon

The prairie dog is valuable for the study of monkeypox virus (MPXV) virulence and closely resembles human systemic orthopoxvirus disease. Herein, we utilize a variable dose intranasal challenge with approximately 10(3), 10(4), 10(5), and 10(6)PFU for each clade to further characterize virulence differences between the two MPXV clades. A trend of increased morbidity and mortality as well as greater viral shedding was observed with increasing viral challenge dose. Additionally, there appeared to be a delay in onset of disease for animals challenged with lower dosages of virus. Mathematical calculations were used to determine LD(50) values and based on these calculations, Congo Basin MPXV had approximately a hundred times lower LD(50) value than the West African clade (5.9x10(3) and 1.29x10(5) respectively); reinforcing previous findings that Congo Basin MPXV is more virulent.


Journal of Clinical Microbiology | 2010

Coxiella burnetii Infection of a Steller Sea Lion (Eumetopias jubatus) Found in Washington State

Gilbert J. Kersh; Dyanna M. Lambourn; Joshua S. Self; Adrianne M. Akmajian; James B. Stanton; Timothy V. Baszler; Stephen Raverty; Robert F. Massung

ABSTRACT A pregnant sea lion stranded in the State of Washington was found to have placentitis caused by a unique strain of Coxiella burnetii. This is the first description of coxiellosis in a sea lion and suggests that exposure to sea lions may be a risk factor for contracting Q fever.


Journal of Wildlife Diseases | 2012

Coxiella burnetii Infection of Marine Mammals in the Pacific Northwest, 1997-2010

Gilbert J. Kersh; Dyanna M. Lambourn; Stephen Raverty; Kelly A. Fitzpatrick; Joshua S. Self; Adrianne M. Akmajian; Steven J. Jeffries; Jessica L. Huggins; Clifton P. Drew; Sherif R. Zaki; Robert F. Massung

Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. Humans are commonly exposed via inhalation of aerosolized bacteria derived from the waste products of domesticated sheep and goats, and particularly from products generated during parturition. However, many other species can be infected with C. burnetii, and the host range and full zoonotic potential of C. burnetii is unknown. Two cases of C. burnetii infection in marine mammal placenta have been reported, but it is not known if this infection is common in marine mammals. To address this issue, placenta samples were collected from Pacific harbor seals (Phoca vitulina richardsi), harbor porpoises (Phocoena phocoena), and Steller sea lions (Eumetopias jubatus). Coxiella burnetii was detected by polymerase chain reaction (PCR) in the placentas of Pacific harbor seals (17/27), harbor porpoises (2/6), and Steller sea lions (1/2) collected in the Pacific Northwest. A serosurvey of 215 Pacific harbor seals sampled in inland and outer coastal areas of the Pacific Northwest showed that 34.0% (73/215) had antibodies against either Phase 1 or Phase 2 C. burnetii. These results suggest that C. burnetii infection is common among marine mammals in this region.


Vector-borne and Zoonotic Diseases | 2011

Virulence of Pathogenic Coxiella burnetii Strains After Growth in the Absence of Host Cells

Gilbert J. Kersh; Lindsay D. Oliver; Joshua S. Self; Kelly A. Fitzpatrick; Robert F. Massung

Coxiella burnetii is a gram-negative bacterium that causes the zoonotic disease Q fever. Traditionally considered an obligate intracellular agent, the requirement to be grown in tissue culture cells, embryonated eggs, or animal hosts has made it difficult to isolate strains and perform genetic studies on C. burnetii. However, it was recently demonstrated that the attenuated Nine Mile Phase 2 (NM2) C. burnetii strain will grow axenically in acidified citrate cysteine medium (ACCM) in a 2.5% oxygen environment. The current study was undertaken to determine whether more virulent C. burnetii strains could be grown in ACCM, and whether virulence would be maintained after passage. The ACCM medium supported an ?1000-fold expansion of Nine Mile Phase 1 (NM1), NM2, M44, and Henzerling strains of C. burnetii, whereas the Priscilla (Q177) strain expanded only 100-fold, and the K strain (Q154) grew poorly in ACCM. To determine if passage in ACCM would maintain the virulence of C. burnetii, the NM1 strain was grown for up to 26 weekly passages in ACCM. C. burnetii maintained in ACCM for 5 or 8 passages maintained full virulence in a mouse model, but NM1 passaged for 23 or 26 times was somewhat attenuated. These data demonstrate that virulent strains of C. burnetii can be successfully passaged in ACCM; however, some strains can lose virulence after extended passage, and other strains grow poorly in this medium. The loss of virulence in axenic culture was associated with some truncation of lipopolysaccharide chains, suggesting a possible mechanism for attenuation.


Clinical Infectious Diseases | 2016

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus–Infected Patients

Kyle Rosenke; Jennifer Adjemian; Vincent J. Munster; Andrea Marzi; Darryl Falzarano; Clayton O. Onyango; Melvin Ochieng; Bonventure Juma; Robert J. Fischer; Joseph Prescott; David Safronetz; Victor Omballa; Collins Owuor; Thomas Hoenen; Allison Groseth; Cynthia Martellaro; Galina E. Zemtsova; Joshua S. Self; Trenton Bushmaker; Kristin L. McNally; Thomas Rowe; Shannon L. Emery; Friederike Feldmann; Brandi N. Williamson; Sonja M. Best; Tolbert Nyenswah; Allen Grolla; James E. Strong; Gary P. Kobinger; Fatorma K. Bolay

BACKGROUND The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public health burden in the region affected by the outbreak. A joint Centers for Disease Control and Prevention/National Institutes of Health diagnostic laboratory was established in Monrovia, Liberia, in August 2014, to provide laboratory diagnostics for Ebola virus. METHODS All blood samples from suspected Ebola virus-infected patients admitted to the Médecins Sans Frontières ELWA3 Ebola treatment unit in Monrovia were tested by quantitative real-time polymerase chain reaction for the presence of Ebola virus and Plasmodium species RNA. Clinical outcome in laboratory-confirmed Ebola virus-infected patients was analyzed as a function of age, sex, Ebola viremia, and Plasmodium species parasitemia. RESULTS The case fatality rate of 1182 patients with laboratory-confirmed Ebola virus infections was 52%. The probability of surviving decreased with increasing age and decreased with increasing Ebola viral load. Ebola virus-infected patients were 20% more likely to survive when Plasmodium species parasitemia was detected, even after controlling for Ebola viral load and age; those with the highest levels of parasitemia had a survival rate of 83%. This effect was independent of treatment with antimalarials, as this was provided to all patients. Moreover, treatment with antimalarials did not affect survival in the Ebola virus mouse model. CONCLUSIONS Plasmodium species parasitemia is associated with an increase in the probability of surviving Ebola virus infection. More research is needed to understand the molecular mechanism underlying this remarkable phenomenon and translate it into treatment options for Ebola virus infection.


Emerging Infectious Diseases | 2016

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak

Emmie de Wit; Darryl Falzarano; Clayton O. Onyango; Kyle Rosenke; Andrea Marzi; Melvin Ochieng; Bonventure Juma; Robert J. Fischer; Joseph Prescott; David Safronetz; Victor Omballa; Collins Owuor; Thomas Hoenen; Allison Groseth; Galina E. Zemtsova; Joshua S. Self; Trenton Bushmaker; Kristin L. McNally; Thomas Rowe; Shannon L. Emery; Friederike Feldmann; Brandi N. Williamson; Tolbert Nyenswah; Allen Grolla; James E. Strong; Gary P. Kobinger; Ute Stroeher; Mark Rayfield; Fatorma K. Bolay; Kathryn C. Zoon

Malaria is a major public health concern in the countries affected by the Ebola virus disease epidemic in West Africa. We determined the feasibility of using molecular malaria diagnostics during an Ebola virus disease outbreak and report the incidence of Plasmodium spp. parasitemia in persons with suspected Ebola virus infection.


Vector-borne and Zoonotic Diseases | 2016

Genotyping and Axenic Growth of Coxiella burnetii Isolates Found in the United States Environment

Gilbert J. Kersh; Rachael A. Priestley; Heidie Hornstra; Joshua S. Self; Kelly A. Fitzpatrick; Brad J. Biggerstaff; Paul Keim; Talima Pearson; Robert F. Massung

Coxiella burnetii is a gram-negative bacterium that is the etiologic agent of the zoonotic disease Q fever. Common reservoirs of C. burnetii include sheep, goats, and cattle. These animals shed C. burnetii into the environment, and humans are infected by inhalation of aerosols. A survey of 1622 environmental samples taken across the United States in 2006-2008 found that 23.8% of the samples contained C. burnetii DNA. To identify the strains circulating in the U.S. environment, DNA from these environmental samples was genotyped using an SNP-based approach to derive sequence types (ST) that are also compatible with multispacer sequence typing methods. Three different sequence types were observed in 31 samples taken from 19 locations. ST8 was associated with goats and ST20 with dairy cattle. ST16/26 was detected in locations with exposure to various animals and also in locations with no direct animal contact. Viable isolates were obtained for all three sequence types, but only the ST20 and ST16/26 isolates grew in acidified citrate cysteine medium (ACCM)-2 axenic media. Examination of a variety of isolates with different sequence types showed that ST8 and closely related isolates did not grow in ACCM-2. These results suggest that a limited number of C. burnetii sequence types are circulating in the U.S. environment and these strains have close associations with specific reservoir species. Growth in ACCM-2 may not be suitable for isolation of many C. burnetii strains.

Collaboration


Dive into the Joshua S. Self's collaboration.

Top Co-Authors

Avatar

Gilbert J. Kersh

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kelly A. Fitzpatrick

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Robert F. Massung

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Inger K. Damon

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Rachael A. Priestley

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sonja Weiss

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Victoria A. Olson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Zachary Braden

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Allison Groseth

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Andrea Marzi

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge